News from ginkgo bioworks A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 18, 2022, 07:00 ET Ginkgo Bioworks and First Serv Announce Plans to Develop and Implement Innovative Global Biosecurity Capabilities in Qatar

Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, and First Serv, a Qatari investment holding company, today...

May 16, 2022, 16:01 ET Ginkgo Bioworks Reports First Quarter 2022 Financial Results

$168 million of Total revenue in Q1 2022, representing an increase of 282% over Q1 2021 11 new Cell Programs added in Q1 2022, representing 175%...

May 09, 2022, 07:00 ET Ginkgo Bioworks Announces Date of First Quarter 2022 Results Presentation

Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that it plans to host a presentation and Q&A...

Apr 22, 2022, 08:00 ET Ginkgo Bioworks to Expand Platform Capabilities in Agricultural Biologicals and Launch Flagship Partnership with Bayer

Planned transaction expands Ginkgo's horizontal platform capabilities to support agricultural biologicals R&D from discovery through formulation and...

Apr 14, 2022, 17:00 ET Light Bio Partners with Ginkgo Bioworks to Optimize the Brightness of Glowing Plants through Bioluminescence Engineering

Light Bio, Inc., a company that is creating bioluminescent plants for home and garden, and Ginkgo Bioworks (NYSE: DNA), the leading horizontal...

Apr 13, 2022, 07:00 ET FREDsense and Ginkgo Bioworks Announce Partnership to Develop Water Quality Biosensors

FREDsense Technologies Corp, a next generation water quality platform company leveraging synthetic biology to build field kits for faster, cheaper,...

Apr 12, 2022, 07:00 ET Persephone Biosciences and Ginkgo Bioworks Announce Collaboration to Develop Novel Therapeutics

Persephone Biosciences Inc., a synthetic biology company reimagining patient and infant health, and Ginkgo Bioworks (NYSE: DNA), the leading...

Apr 11, 2022, 07:00 ET Elanco and Ginkgo Bioworks Launch BiomEdit, a New Animal Health Company Leveraging Microbiome Technology

Elanco Animal Health Incorporated (NYSE: ELAN), a leading global animal health company, and Ginkgo Bioworks, the leading horizontal platform for cell ...

Apr 04, 2022, 07:00 ET Microba Life Sciences and Ginkgo Bioworks Announce Partnership to Discover Novel Live Biotherapeutics

Microba Life Sciences (ASX:MAP), a precision microbiome science company, and Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell...

Mar 28, 2022, 16:01 ET Ginkgo Bioworks Reports Fourth Quarter and Full Year 2021 Financial Results

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), the leading horizontal platform for cell programming, today announced its results for the...

Mar 23, 2022, 07:00 ET CDC, Concentric by Ginkgo and XpresCheck® Publish Results of CDC COVID-19 Air Travel Biosecurity Program at International Airports

Concentric by Ginkgo, the public health and biosecurity initiative of Ginkgo Bioworks (NYSE: DNA), today released new findings from its joint...

Mar 17, 2022, 08:15 ET Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2021 Results Presentation and Date for Annual Meeting of Shareholders

Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that it plans to host a presentation and Q&A...

Mar 15, 2022, 07:00 ET Ginkgo Bioworks Announces Participation in Jefferies Virtual Synthetic Biology Week

Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that management is scheduled to participate in a...

Mar 14, 2022, 07:00 ET Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen AG, a leading bioengineering company and its proprietary ultra-high-throughput screening platform

Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced the entry into a definitive agreement to acquire...

Feb 24, 2022, 07:00 ET Ginkgo Bioworks Announces Participation in Upcoming Conferences

Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that management is scheduled to participate in the ...

Feb 08, 2022, 16:00 ET Ginkgo Bioworks Announces Participation in Upcoming Conferences

Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that management is scheduled to participate in the ...

Jan 19, 2022, 07:00 ET Ginkgo Bioworks Announces Acquisition of Massachusetts COVID-19 Testing Provider Project Beacon COVID-19 LLC

Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced the acquisition of Project Beacon COVID-19 LLC...

Jan 12, 2022, 07:00 ET Ginkgo Bioworks Provides Preliminary Unaudited 2021 Revenue Highlights and Business Review

Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today preliminary performance updates for the year ended ...

Jan 10, 2022, 07:00 ET Selecta Biosciences and Ginkgo Bioworks Announce New Collaboration to Develop Next-Generation Gene Therapy Capsids

Selecta Biosciences, Inc. (Nasdaq: SELB), a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic...

Jan 06, 2022, 07:00 ET Optimvia and Ginkgo Bioworks Announce Partnership to Manufacture Biosynthetic Heparin

Optimvia, a biotechnology company specializing in engineering enzymes and their cofactors to synthesize complex therapeutic molecules, and Ginkgo...

Jan 05, 2022, 07:00 ET Ginkgo Bioworks Announces Participation in 40th Annual J.P. Morgan Healthcare Conference

Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that Co-Founder and CEO Jason Kelly is scheduled...

Dec 20, 2021, 07:00 ET Benjamin Franklin Institute of Technology, Ginkgo Bioworks to Develop Biotechnology Manufacturing Associates Degree

Benjamin Franklin Institute of Technology (BFIT), a private non-profit college offering affordable education for people seeking technical and trade...

Dec 18, 2021, 00:33 ET Concentric by Ginkgo and XpresCheck™ Confirm First North American Detections of Novel BA.3 Sublineage of Omicron Variant through CDC COVID-19 Air Travel Biosecurity Program

Ginkgo Bioworks (NYSE: DNA) today confirmed that it has collected, identified, and sequenced three samples containing the novel BA.3 sublineage of...

Dec 07, 2021, 07:00 ET Concentric by Ginkgo Confirms Detection of Omicron Variant through COVID-19 Air Travel Biosecurity Collaboration with CDC and XpresCheck

Ginkgo Bioworks (NYSE: DNA) today confirmed that it has collected, identified, and sequenced a pooled sample containing the Omicron variant from...

Nov 24, 2021, 07:00 ET Ginkgo Bioworks Announces Participation in Upcoming Conferences

Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that management is scheduled to participate in the ...